USP9X and atherosclerosis: Although the regulation of USP9X by noncoding RNAs in the context of atherosclerosis is still unknown, the current evidence suggests that it is worth investigating the underlying mechanism with a view to developing a therapeutic USP9X agonist for atherosclerosis.